phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

MedMon_Catalyst_Banner.jpg

We took a deeper dive on Medicare Part D last week, so today we’re switching gears and talking about Medicare Part B.

What Does Part B Cover?

Part B covers physician office benefits, outpatient care and medical equipment, as well as medicines that are usually administered by a physician. Part B medicines are often used to treat patients with serious and complex conditions – conditions including cancer, rheumatoid arthritis and mental health, among others. These vulnerable patients have few or no other treatment options and are reliant on Part B therapies.

How Does Part B Pay for Medicines?

Medicare providers negotiate directly with manufacturers and wholesalers to purchase Part B medicines and are then reimbursed by Medicare. The reimbursement methodology for Part B medicines is Average Sales Price (ASP) plus 6 percent. ASP is a market-based price and is reflective of the weighted average of all manufacturer sales prices. As a result, it includes the rebates and discounts that are privately negotiated between manufacturers and purchasers. The 6 percent add-on payment accounts for geographic and provider purchasing variability and the additional costs associated with the complexity of Part B drugs, such as storage and handling and ongoing patient monitoring and education.

ASP+6% mirrors reimbursement for physician-administered drugs in the commercial market and has been found to be an effective reimbursement methodology. For example, research from The Moran Company released in December found that volume-weighted ASP has remained steady year over year. A recent report from the Department of Health and Human Services also found that spending on Part B medicines has remained a small share of overall Part B spending, with only moderate increases from 2007 to the present. These finding suggest medicines are not a key driver of Part B spending.

Learn more about Medicare Part B at PhRMA.org/PartB.

Kelsey Lang

What AARP isn’t telling seniors about MFN

August 24, 2026

CMS proposal could discourage patient-centered innovation

August 18, 2026

Nearly 1 in 4 patients initially denied access to IRA medicines

August 6, 2026

Medicare Part D at 20: Building on a strong foundation

July 23, 2026

Medicare Monday: A closer look at Medicare Part B

Medicare

Medicare Monday

Part B

Medicare Monday: A closer look at Medicare Part B

January 16, 2017

Medicare Monday: A closer look at Medicare Part B

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list